TLDR Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.
The review hypothesized that frontal fibrosing alopecia (FFA) might result from excessive facial photoprotection, disrupting immunological homeostasis mediated by the aryl hydrocarbon receptor (AHR)-kynurenine pathway (KP) axis, leading to immune privilege collapse at the hair follicle's bulge area. It suggested that a certain level of sun exposure is necessary to maintain skin immunological balance, and the rising incidence of FFA might be linked to environmental factors, including the use of sunscreens and facial care products. The study highlighted the complex interplay between AHR activity, immune regulation, and hair follicle health, proposing that disruptions in these pathways could lead to the immune-mediated destruction of hair follicles seen in FFA.
34 citations,
June 2020 in “British journal of dermatology/British journal of dermatology, Supplement” Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.
26 citations,
October 2018 in “British Journal of Dermatology” Regular use of sunscreen may be linked to frontal fibrosing alopecia.
80 citations,
April 2018 in “Trends in Molecular Medicine” Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.
51 citations,
December 2017 in “Skin Appendage Disorders” Stress may trigger hair loss by affecting immune protection in hair follicles.
38 citations,
January 2017 in “PPAR Research” PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.
220 citations,
June 2013 in “The Journal of Pathology” 21 citations,
June 2011 in “Investigative Ophthalmology & Visual Science” Hair follicles could help develop eye treatments by studying immune responses.
13 citations,
June 2020 in “International Journal of Dermatology” A rare scalp condition mainly in older women can be treated with various alternatives to steroids, which may have fewer side effects.